https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=27355506&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 273555062017060820200930
1944-788472 Suppl 2Suppl 22016Aug01Journal of acquired immune deficiency syndromes (1999)J Acquir Immune Defic SyndrModeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya.S174S180S174-8010.1097/QAI.0000000000001057Women in sub-Saharan Africa face a 2-fold higher risk of HIV acquisition during pregnancy and postpartum and the majority do not know the HIV status of their male partner. Home-based couple HIV testing for pregnant women can reduce HIV transmission to women and infants while increasing antiretroviral therapy (ART) coverage in men. However, the cost-effectiveness of this program has not been evaluated.We modeled the health and economic impact of implementing a home-based partner education and HIV testing (HOPE) intervention for pregnant women and their male partners in a region of Western Kenya (formally Nyanza Province). We used data from the HOPE randomized clinical trial conducted in Kisumu, Kenya, to parameterize a mathematical model of HIV transmission. We conducted an in-country microcosting of the HOPE intervention (payer perspective) to estimate program costs as well as a lower cost scenario of task-shifting to community health workers.The incremental cost of adding the HOPE intervention to standard antenatal care was $31-37 and $14-16 USD per couple tested with program and task-shifting costs, respectively. At 60% coverage of male partners, HOPE was projected to avert 6987 HIV infections and 2603 deaths in Nyanza province over 10 years with an incremental cost-effectiveness ratio (ICER) of $886 and $615 per disability-adjusted life year averted for the program and task-shifting scenario, respectively. ICERs were robust to changes in intervention coverage, effectiveness, and ART initiation and dropout rates.The HOPE intervention can moderately decrease HIV-associated morbidity and mortality by increasing ART coverage in male partners of pregnant women. ICERs fall below Kenya's per capita gross domestic product ($1358) and are therefore considered cost-effective. Task-shifting to community health workers can increase intervention affordability and feasibility.SharmaMonishaM*Department of Epidemiology, University of Washington, Seattle, WA; †Department of Global Health, University of Washington, Seattle, WA; ‡School of Medicine, University of Washington, Seattle, WA; Departments of §Research and Programs; ‖Reproductive Health, Kenyatta National Hospital, Nairobi, Kenya; ¶Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; and #Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA.FarquharCareyCYingRogerRKrakowiakDaisyDKinuthiaJohnJOsotiAlfredAAsilaVictorVGoneMollyMMarkJenniferJBarnabasRuanne VRVengK24 AI087399AINIAID NIH HHSUnited StatesK43 TW010363TWFIC NIH HHSUnited StatesR01 HD075108HDNICHD NIH HHSUnited StatesT32 AI007140AINIAID NIH HHSUnited StatesJournal Article
United StatesJ Acquir Immune Defic Syndr1008920051525-4135IMAIDS Serodiagnosiseconomicsstatistics & numerical dataCost-Benefit AnalysisFemaleHIV Infectionsdiagnosisprevention & controltransmissionHome Care ServicesHumansKenyaMaleModels, EconomicPatient Education as TopicPregnancySexual PartnersThe authors have no funding or conflicts of interest to disclose.
2016630602016630602017696020161117ppublish27355506PMC511323610.1097/QAI.000000000000105700126334-201608011-00012UNAIDS. 2013 Report on the Global AIDS Epidemic. Available at: http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport. Accessed May 22, 2015.Leroy V, Van de Perre P, Lepage P, et al. Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS. 1994;8:983–986.7946110Taha TE, Dallabetta GA, Hoover DR, et al. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998;12:197–203.9468369Humphrey JH, Hargrove JW, Malaba LC, et al. HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS. 2006;20:1437–1446.16791019Kinuthia J, Kiarie JN, Farquhar C, et al. Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res. 2010;8:510–514.PMC337239920946093Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366:1182–1188.16198767Calvert C, Ronsmans C. The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis. AIDS. 2013;27:1631–1639.PMC367888423435296WHO. Global Update on the Health Sector Response to HIV. 2014. Available at: http://apps.who.int/iris/bitstream/10665/128494/1/9789241507585_eng.pdf?ua=1. Accessed Ocotber 16, 2015.UNAIDS. Kenya AIDS Response Progress Report. 2014. Available at: http://www.unaids.org/sites/default/files/country/documents/KEN_narrative_report_2014.pdf. Accessed January 20, 2016.Bellan SE, Fiorella KJ, Melesse DY, et al. Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data. Lancet. 2013;381:1561–1569.PMC370383123391466Kranzer K, Govindasamy D, Ford N, et al. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15:17383.PMC350323723199799UNAIDS World AIDS Day Report 2012. Available at: http://www.unaids.org/sites/default/files/media_asset/JC2434_WorldAIDSday_results_en_1.pdf. Accessed May 25, 2015.Paulin HN, Blevins M, Koethe JR, et al. HIV testing service awareness and service uptake among female heads of household in rural Mozambique: results from a province-wide survey. BMC Public Health. 2015;15:1388.PMC433924125881182Suthar AB, Ford N, Bachanas PJ, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med. 2013;10:e1001496.PMC374244723966838Ebuy H, Yebyo H, Alemayehu M. Level of adherence and predictors of adherence to the Option B+ PMTCT programme in Tigray, northern Ethiopia. Int J Infect Dis. 2015;33:123–129.25529555Becker S, Mlay R, Schwandt HM, et al. Comparing couples' and individual voluntary counseling and testing for HIV at antenatal clinics in Tanzania: a randomized trial. AIDS Behav. 2010;14:558–566.19763813Rosenberg NE, Mtande TK, Saidi F, et al. Recruiting male partners for couple HIV testing and counselling in Malawi's option B+ programme: an unblinded randomised controlled trial. Lancet HIV. 2015;2:e483–e491.PMC465679026520928Cornell M, McIntyre J, Myer L. Men and antiretroviral therapy in Africa: our blind spot. Trop Med Int Health. 2011;16:828–829.PMC374937421418449Kenya AIDS Indicator Survey 2012. Available at: http://www.nacc.or.ke/images/documents/KAIS-2012.pdf. Accessed January 1, 2016.Krakowiak D, Kinuthia J, Osoti AO, et al. Home-based HIV testing among pregnant couples increases partner testing and identification of serodiscordant partnerships. J Acquir Immune Defic Syndr. 2016;72(suppl 2):S167–S173.PMC511323927355505Ying R, Sharma M, Heffron R, et al. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda. J Int AIDS Soc. 2015;18(4 suppl 3):20013.PMC450990126198348Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–2098.PMC292204120537376Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129–2143.PMC1078281123245605Mills EJ, Bakanda C, Birungi J, et al. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS. 2011;25:851–855.21330903Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;371:1603–1611.PMC238719718468544MATLAB and Statistics Toolbox Release. Natick, MA: The MathWorks, Inc; 2015.World Bank Development Indicators: Antiretroviral Therapy Coverage (% of People Living with HIV). Available at: http://data.worldbank.org/indicator/SH.HIV.ARTC.ZS?page=1. Accessed February 2, 2016.Drummond M, Drummond M. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed Oxford; NY: Oxford University Press; 2005.UNAIDS. Costing Guidelines for HIV Prevention Strategies. Geneva, Switzerland: UNAIDS; 2000. Available at: http://data.unaids.org/Publications/IRC-pub05/jc412-costguidel_en.pdf. Accessed March 3, 2016.Obure CD, Vassall A, Michaels C, et al. Optimising the cost and delivery of HIV counselling and testing services in Kenya and Swaziland. Sex Transm Infect. 2012;88:498–503.PMC359549822859498Tagar E, Sundaram M, Condliffe K, et al. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia. PloS One. 2014;9:e108304.PMC422908725389777Meyer-Rath G, Brennan AT, Fox MP, et al. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2013;62:322–328.PMC362567323187948Gold MR. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.Fasawe O, Avila C, Shaffer N, et al. Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi. PloS One. 2013;8:e57778.PMC359526623554867Smith JA, Sharma M, Levin C, et al. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV. 2015;2:e159–e168.PMC438481925844394Cornell M, Myer L. Men and mortality: sex inequality in health outcomes. AIDS. 2013;27:849–850.23719356One million community health workers. Technical Task Force Report. Available at: http://frontlinehealthworkers.org/wp-content/uploads/2014/09/CHW-Report.pdf. Accessed January 24, 2016.Chamie G, Clark TD, Kabami J, et al. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016;3:e111–e119.PMC478022026939734Brown LB, Miller WC, Kamanga G, et al. Predicting partner HIV testing and counseling following a partner notification intervention. AIDS Behav. 2012;16:1148–1155.PMC351568522120879Sharma M, Ying R, Tarr G, et al. Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa. Nature. 2015;528:S77–S85.PMC477896026633769Bassett IV, Govindasamy D, Erlwanger AS, et al. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PloS One. 2014;9:e85197.PMC389896324465503